Improving Quality of Life in Nursing Home Residents: A Cluster Randomized Clinical Trial of Efficacy

Summary

Improving quality of life (QoL) in residents of nursing homes:

A cluster randomized clinical trial of efficacy - The KOSMOS study.

COSMOS (COmmunication (Advance Care Planning - ACP), Systematic pain assessment and treatment, Medication review, Occupational therapy, and Safety) is a practical intervention aimed to improve clinical and psychiatric challenges in NH patients. The COSMOS intervention combines the most effective research results to improve staff competence and patients' mental health, safety, QoL. We also aim to reduce psychotropic drug use and costs.

Conditions

• Quality of Life

Interventions

BEHAVIORAL

Communication

A preparation process before the patient become incapable of participating in life prolonging decisions

BEHAVIORAL

Systematic Pain Assessment and Treatment

Assess pain with MOBID-2 Pain Scale and thereby improve pain management in dementia.

BEHAVIORAL

Medication Review

An individual and systematic review of medication prescriptions to identify possible harmful drug effects and to reduce the use of psychotropic drugs.

BEHAVIORAL

Occupational therapy

Increase individual activities, based on function, personal interest and personality by educating the staff on these elements.

BEHAVIORAL

Safety

Focusing on developing a culture where staff has an active and constant awareness of how to prevent adverse events and a commitment to safety.

Sponsors & Collaborators

• The Research Council of Norway

  collaborator OTHER

• Rebekka Ege Hegemanns legat

  collaborator UNKNOWN

• Helse Stavanger HF

  collaborator OTHER_GOV

• University of Oslo

  collaborator OTHER

• King's College London

  collaborator OTHER

• Karolinska Institutet

  collaborator OTHER

• University of Bergen

  lead OTHER

Principal Investigators

• Bettina S. Husebø, MD, PhD · University of Bergen

• Elisabeth Flo, PysD, PhD · University of Bergen

• Irene Aasmul, Master · University of Bergen

• Christine Gulla, MD · University of Bergen

• Torstein Habiger · University of Bergen

• Tony Elvegaard · University of Bergen

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2014-08-31

Primary Completion

2015-11-30

Completion

2015-11-30

Countries

• Norway

Study Locations